Using the medidux smartphone app to manage discharge from the Acute Admission Unit
Official title: Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU): a Randomized Controlled Trial.
Run by Mobile Health AG · NCT06655337 · Data updated 2026-11-12
We will test whether adults discharged from the Acute Admission Unit with cough, back pain, or abdominal discomfort who use the medidux app are less likely to return or need extra medical visits within 7 days.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 417 (estimated) |
| Sponsor | Mobile Health AG Industry-sponsored |
| Locations | 1 site (Horgen, Canton of Zurich) |
| Status | Recruiting |
| Started | September 28, 2025 |
| Main results expected | March 28, 2027 |
| Study ends | March 28, 2027 |
| Registry record updated | October 3, 2025 |
| Trial ID | NCT06655337 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older, triaged as ESI 4 or 5 at AAU presentation with a primary complaint of cough, back pain, or abdominal discomfort, who speak German and own an iOS or Android smartphone.
✕Probably not a fit
Patients with urgent or severe conditions, those without a compatible smartphone or sufficient smartphone skills, non-German speakers, or people already using a similar monitoring system are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares the medidux smartphone app with standard post-discharge care for adults admitted to an Acute Admission Unit with non-urgent complaints such as cough, back pain, or abdominal discomfort. Eligible participants use the app to report symptoms and basic vital signs daily for seven days after discharge while a control group receives usual care. Investigators will compare rates of AAU readmission, emergency hospitalizations, and consultations with other medical providers within seven days. The trial is run at Notfallzentrum See-Spital Horgen and requires German-speaking participants who own a smartphone.
Why it matters
Potential benefit: If successful, the app could reduce short-term returns to the AAU and unplanned medical visits by improving symptom monitoring and early guidance after discharge.
How similar studies have gone: Previous digital symptom-monitoring and post-discharge apps have shown mixed but sometimes positive results in reducing readmissions in selected settings, though evidence is limited for non-urgent AAU discharges.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed Informed Consent Form (ICF) * Age ≥ 18 years * (Self-)admission to the involved Acute Admissions Unit (AAU) * "Lead symptom" identified as coughing, back pain or abdominal discomfort * Participant within ESI triage system group 4 (standard) and 5 (non-urgent) * German-speaking * Ownership of a smartphone or other mobile device with iOS or Android operating system Exclusion Criteria: * Age \< 18 years * Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted * Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system * Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial
Where it's running
-
Notfallzentrum See-Spital Horgen
Horgen, Canton of Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Andreas Trojan, MD
- Email: andreas.trojan@mobilehealth.ch
- Phone: +41763430200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-simplified discharge summaries to improve patient understanding
This randomized pilot tests whether ContextCare can help adults understand their discharge information better than standard discharge words and printouts.
-
Tele-diabetes remote monitoring for kids with type 1 diabetes
This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.
-
Transauricular Neurostimulation for Abdominal Pain in Teens
We are testing a head- and ear‑based device to see if it helps teens with abdominal pain from gut-brain disorders.
-
How movement and nervous system function relate after stroke
This study tests whether measures of movement efficiency and nerve function relate to outcomes in adults who had a stroke.
-
Does an Enhanced Recovery After Surgery (ERAS) plan reduce preoperative anxiety and improve 1-year patient-reported outcomes in orthopedic patients?
This study tests whether an ERAS program can lower preoperative anxiety and improve long-term patient-reported outcomes after orthopedic surgery.
-
Digital support to improve quality of life for people with multiple myeloma
This study tests a personalized web-based platform to see if it improves quality of life for adults with multiple myeloma who can use the digital tool.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.